
Mesoblast reports $US35.1m in gross revenue from sales of its cell therapy Ryoncil
Mesoblast Ltd (NASDAQ:MESO, ASX:MSB) reported $US35.1 million ($52.4 million) in gross revenue from Ryoncil sales in the December quarter, up 60% on the...
Loading news...

Mesoblast Ltd (NASDAQ:MESO, ASX:MSB) reported $US35.1 million ($52.4 million) in gross revenue from Ryoncil sales in the December quarter, up 60% on the...

NEW YORK , Dec. 11, 2025 /PRNewswire/ -- Loews Corporation (NYSE: L) announced today that the Delaware Supreme Court issued a ruling in the litigation relating to its 2018 acquisition of the minority limited partner interests in its Boardwalk Pipelines subsidiary. The Supreme Court found that there was a breach in connection with the underlying partnership agreement and remanded the issue of whether Loews was liable for tortious interference back to the Delaware Court of Chancery.

Boston Partners cut its holdings in Loews Corporation (NYSE: L) by 1.2% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 1,475,946 shares of the insurance provider's stock after selling 17,628 shares during the period. Boston Partners owned about 0.71% of Loews worth $135,313,000 as

Representative Lisa C. McClain (R-Michigan) recently sold shares of Loews Corporation (NYSE: L). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Loews stock on October 31st. The trade occurred in the Representative's "CHARLES SCHWAB 401K > SCHWAB 893" account. Representative Lisa C. McClain also recently

Creative Planning boosted its stake in shares of Loews Corporation (NYSE: L) by 3.3% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 27,210 shares of the insurance provider's stock after acquiring an additional 879 shares during the quarter.

Cardinal Health gained nearly 74% year to date, and it has the potential to keep climbing. Loews doesn't own the most exciting portfolio of businesses, but the conglomerate has been steadily gaining over the past 12 months.

NEW YORK , Nov. 11, 2025 /PRNewswire/ -- Loews Corporation (NYSE: L) announced today the declaration of the Company's quarterly dividend of $0.0625 per share of Common Stock, payable December 9, 2025 to shareholders of record as of the close of business on November 26, 2025. Loews Corporation is a diversified company with businesses in the insurance, energy, hospitality, and packaging industries.

Spire Wealth Management reduced its position in shares of Loews Corporation (NYSE: L) by 77.9% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,026 shares of the insurance provider's stock after selling 3,615 shares during the period.

NEW YORK , Nov. 3, 2025 /PRNewswire/ -- Loews Corporation (NYSE: L) announced today that Dino Robusto has been elected a director of Loews, effective January 1, 2026. Mr. Robusto was the Chief Executive Officer and Chairman of the Board of Loews's subsidiary, CNA Financial Corporation (NYSE: CNA), from 2016 until 2024, and has served as Executive Chairman of CNA during 2025.

NEW YORK , Nov. 3, 2025 /PRNewswire/ -- Loews Corporation (NYSE: L) today released its third quarter 2025 financial results. Third Quarter 2025 highlights: Loews Corporation reported net income of $504 million, or $2.43 per share, in the third quarter of 2025, compared to $401 million, or $1.82 per share, in the third quarter of 2024.

NEW YORK , Oct. 14, 2025 /PRNewswire/ -- Loews Corporation (NYSE: L) will report third quarter 2025 financial results on Monday, November 3, 2025. On that date the Company will also post earnings remarks on its website.

Jason Brown (@brownreport) turns away from A.I. high-flyers and turns investor attention to three under the radar stocks where he sees significant upside potential.

On 8/20/25, Loews, AFLAC, and Marketaxess Holdings will all trade ex-dividend for their respective upcoming dividends. Loews will pay its quarterly dividend of $0.0625 on 9/2/25, AFLAC will pay its quarterly dividend of $0.58 on 9/2/25, and Marketaxess Holdings will pay its quarterly dividend of $0.76 on 9/3/25.

NEW YORK , Aug. 5, 2025 /PRNewswire/ -- Loews Corporation (NYSE:L) announced today that Jennifer VanBelle has been elected a director of Loews and appointed as a member of its Audit Committee. Ms. VanBelle spent more than 25 years at General Electric Company in positions of increasing responsibility, which culminated in her holding three roles simultaneously: Senior Vice President, Treasurer; Chief Executive Officer, GE Capital; and Senior Vice President, GE Separation Leader.

NEW YORK , Aug. 5, 2025 /PRNewswire/ -- Loews Corporation (NYSE: L) announced today the declaration of the Company's quarterly dividend of $0.0625 per share of Common Stock, payable September 2, 2025 to shareholders of record as of the close of business on August 20, 2025. Loews Corporation is a diversified company with businesses in the insurance, energy, hospitality, and packaging industries.

Loews (L) Q2 EPS Jumps 12%

NEW YORK , Aug. 4, 2025 /PRNewswire/ -- Loews Corporation (NYSE: L) today released its second quarter 2025 financial results. Second Quarter 2025 highlights: Loews Corporation reported net income of $391 million, or $1.87 per share, in the second quarter of 2025, compared to $369 million, or $1.67 per share, in the second quarter of 2024.

NEW YORK , July 15, 2025 /PRNewswire/ -- Loews Corporation (NYSE: L) will report second quarter 2025 financial results on Monday, August 4, 2025. On that date the Company will also post earnings remarks on its website.

New Engen, a digital marketing agency accelerating brand growth through media, creative, and data, will lead digital strategy for Loews Hotels as their digital marketing agency of record New Engen, a digital marketing agency accelerating brand growth through media, creative, and data, will lead digital strategy for Loews Hotels as their digital marketing agency of record

DALLAS and SHANGHAI, May 23, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil") and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKEX Code: 1541.HK, “ImmuneOnco”), today announced that they will jointly host an investor and research analyst breakfast in Chicago, Illinois on Saturday, May 31, 2025 at 8:00 to 9:30 am CT adjacent to the McCormick Convention Center.